Effects of aldose reductase inhibitor on the peripheral nerve function during ischemia in diabetics.
D000200:Action Potentials / Q000187:drug effects; D000293:Adolescent; D000328:Adult; D000449:Aldehyde Reductase / Q000037:antagonists & inhibitors*; D001132:Arm / Q000098:blood supply* / Q000294:innervation; D002648:Child; D003929:Diabetic Neuropathies / Q000188:drug therapy / Q000503:physiopathology*; D005260:Female; D006801:Humans; D007511:Ischemia / Q000503:physiopathology*; D008297:Male; D008875:Middle Aged; D010525:Peripheral Nerves / Q000503:physiopathology*; D012236:Rhodanine / Q000031:analogs & derivatives / Q000494:pharmacology*; D013401:Sugar Alcohol Dehydrogenases / Q000037:antagonists & inhibitors*; D013844:Thiazoles / Q000494:pharmacology*; D053778:Thiazolidines
D013844:Thiazoles; D053778:Thiazolidines; C038131:epalrestat; D012236:Rhodanine; D013401:Sugar Alcohol Dehydrogenases; D000449:Aldehyde Reductase